van der Velden TJAM - Search Results

1

Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: In V itro Detection.

Veissi ST, Smeets B, van Wijk JAE, Classens R, van der Velden TJAM, Jeronimus-Klaasen A, Veltkamp F, Mak-Nienhuis EM, Morello W, Montini G, Bouts AHM, van den Heuvel LPWJ, Schreuder MF. Veissi ST, et al. Among authors: van der velden tjam. Kidney Int Rep. 2022 Sep 20;7(12):2691-2703. doi: 10.1016/j.ekir.2022.09.014. eCollection 2022 Dec. Kidney Int Rep. 2022. PMID: 36506233 Free PMC article.

2

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA. van Setten PA, et al. Kidney Int. 1997 Apr;51(4):1245-56. doi: 10.1038/ki.1997.170. Kidney Int. 1997. PMID: 9083293 Free article.

3

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.

Van Setten PA, van Hinsbergh VW, Van den Heuvel LP, van der Velden TJ, van de Kar NC, Krebbers RJ, Karmali MA, Monnens LA. Van Setten PA, et al. J Am Soc Nephrol. 1997 Dec;8(12):1877-88. doi: 10.1681/ASN.V8121877. J Am Soc Nephrol. 1997. PMID: 9402090

4

Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.

van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA. van Setten PA, et al. Pediatr Res. 1998 Jun;43(6):759-67. doi: 10.1203/00006450-199806000-00008. Pediatr Res. 1998. PMID: 9621985

5

Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.

te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW. te Loo DM, et al. Blood. 2000 Jun 1;95(11):3396-402. Blood. 2000. PMID: 10828021 Free article.

6

Anticardiolipin antibodies in D+ hemolytic uremic syndrome.

te Loo M, van der Velden T, Onland W, van den Heuvel L, Monnens L. te Loo M, et al. Pediatr Nephrol. 2002 Dec;17(12):1042-6. doi: 10.1007/s00467-002-0965-4. Epub 2002 Nov 1. Pediatr Nephrol. 2002. PMID: 12478355 Clinical Trial.

7

Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Te Loo DM, Monnens L, van der Velden T, Karmali M, van den Heuvel L, van Hinsbergh V. Te Loo DM, et al. Pediatr Nephrol. 2006 Dec;21(12):1815-23. doi: 10.1007/s00467-006-0232-1. Epub 2006 Aug 30. Pediatr Nephrol. 2006. PMID: 16944213

8

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.

Geelen JM, van der Velden TJ, Te Loo DM, Boerman OC, van den Heuvel LP, Monnens LA. Geelen JM, et al. Nephrol Dial Transplant. 2007 Mar;22(3):749-55. doi: 10.1093/ndt/gfl688. Epub 2006 Nov 24. Nephrol Dial Transplant. 2007. PMID: 17127697

9

Interactions of Shiga-like toxin with human peripheral blood monocytes.

Geelen JM, van der Velden TJ, van den Heuvel LP, Monnens LA. Geelen JM, et al. Pediatr Nephrol. 2007 Aug;22(8):1181-7. doi: 10.1007/s00467-007-0512-4. Epub 2007 May 22. Pediatr Nephrol. 2007. PMID: 17574480 Free PMC article.

10

Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate.

Geelen J, Valsecchi F, van der Velden T, van den Heuvel L, Monnens L, Morigi M. Geelen J, et al. Nephrol Dial Transplant. 2008 Oct;23(10):3091-5. doi: 10.1093/ndt/gfn244. Epub 2008 May 9. Nephrol Dial Transplant. 2008. PMID: 18469308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page